131 related articles for article (PubMed ID: 9130634)
1. Selective down-regulation of Th2 immune responses following treatment with antigen-coupled splenocytes.
Soldera S; McSorley SJ; Glaichenhaus N
Eur J Immunol; 1997 Apr; 27(4):848-54. PubMed ID: 9130634
[TBL] [Abstract][Full Text] [Related]
2. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
[TBL] [Abstract][Full Text] [Related]
3. Non-MHC-linked Th2 cell development induced by soluble protein administration predicts susceptibility to Leishmania major infection.
Guéry JC; Galbiati F; Smiroldo S; Adorini L
J Immunol; 1997 Sep; 159(5):2147-53. PubMed ID: 9278301
[TBL] [Abstract][Full Text] [Related]
4. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
6. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
[TBL] [Abstract][Full Text] [Related]
7. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis.
Sjölander A; Baldwin TM; Curtis JM; Handman E
J Immunol; 1998 Apr; 160(8):3949-57. PubMed ID: 9558102
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
9. [LACK protein of Leishmania major: a pivotal antigen in the immune relation between host and parasite].
Gangneux JP
Sante; 1997; 7(6):425. PubMed ID: 9503502
[No Abstract] [Full Text] [Related]
10. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pulmonary T cell responses to inhaled antigen: role in Th1- and Th2-mediated inflammation.
Lee SC; Jaffar ZH; Wan KS; Holgate ST; Roberts K
J Immunol; 1999 Jun; 162(11):6867-79. PubMed ID: 10352309
[TBL] [Abstract][Full Text] [Related]
12. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
von der Weid T; Beebe AM; Roopenian DC; Coffman RL
J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817
[TBL] [Abstract][Full Text] [Related]
13. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.
Maekawa Y; Himeno K; Ishikawa H; Hisaeda H; Sakai T; Dainichi T; Asao T; Good RA; Katunuma N
J Immunol; 1998 Sep; 161(5):2120-7. PubMed ID: 9725203
[TBL] [Abstract][Full Text] [Related]
14. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
Mazumdar T; Anam K; Ali N
Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
16. Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses.
Desmedt M; Rottiers P; Dooms H; Fiers W; Grooten J
J Immunol; 1998 Jun; 160(11):5300-8. PubMed ID: 9605128
[TBL] [Abstract][Full Text] [Related]
17. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage.
Franco L; Benedetti R; Ferek GA; Massouh E; Fló J
Cell Immunol; 1998 Nov; 190(1):1-11. PubMed ID: 9826441
[TBL] [Abstract][Full Text] [Related]
18. Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation.
Constant SL; Lee KS; Bottomly K
Eur J Immunol; 2000 Mar; 30(3):840-7. PubMed ID: 10741400
[TBL] [Abstract][Full Text] [Related]
19. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
Wakil AE; Wang ZE; Locksley RM
Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
Mocci S; Coffman RL
J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
